Status:
COMPLETED
Effect of APC and Epo on the Inflammatory Response During Sepsis
Lead Sponsor:
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Conditions:
Sepsis
Systemic Inflammation
Eligibility:
All Genders
18+ years
Brief Summary
An observational study to determine the effect of APC and Epo in reducing the systemic inflammatory response during severe sepsis.
Detailed Description
An observational study to determine the effect of APC and Epo in reducing the systemic inflammatory response during severe sepsis. Patients already prescribed either drug will be enrolled. The microci...
Eligibility Criteria
Inclusion
- patients in the ICU in severe septic shock undergoing APC and/or Epo treatment
Exclusion
- any severe comorbid conditions
Key Trial Info
Start Date :
September 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2011
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00229034
Start Date
September 1 2005
End Date
September 1 2011
Last Update
August 25 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lawson Health Research Institute
London, Ontario, Canada, N6A 4G5